Who owns Crinetics Pharmaceuticals, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of CRNX from SEC Form 13F filings across 268 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 268 institutions disclosed 123.7M shares of Crinetics Pharmaceuticals, Inc. worth $4.63B — about 117.1% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
268
13F holders
$4.63B
value, 2026 filers
117.1%
of shares outstanding (123.7M sh)
58
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of CRNX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 15.8M | $592.7M | 0.0% | 15% | +0.5% |
| 2 | BlackRock, Inc. | 9.8M | $365.2M | 0.0% | 9.2% | +15.1% |
| 3 | FARALLON CAPITAL MANAGEMENT, L.L.C. | 9.0M | $336.4M | 1.6% | 8.5% | +7.8% |
| 4 | WELLINGTON MANAGEMENT GROUP LLP | 7.1M | $266.8M | 0.0% | 6.8% | -12.6% |
| 5 | Driehaus Capital Management LLC | 6.5M | $241.9M | 1.4% | 6.1% | +1.1% |
| 6 | PRICE T ROWE ASSOCIATES INC /MD/ | 6.2M | $232.5M | 0.0% | 5.9% | +16.0% |
| 7 | VANGUARD PORTFOLIO MANAGEMENT LLC | 4.8M | $180.8M | 0.0% | 4.6% | +4.2% |
| 8 | VANGUARD CAPITAL MANAGEMENT LLC | 4.7M | $177.6M | 0.0% | 4.5% | +1.5% |
| 9 | Jupiter Topco LLCNEW | 4.6M | $170.5M | 0.1% | 4.3% | new |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 2.7M | $102.1M | 0.0% | 2.6% | +10.0% |
| 11 | STATE STREET CORP | 2.7M | $100.6M | 0.0% | 2.5% | +11.9% |
| 12 | Bellevue Group AG | 2.6M | $98.0M | 2.1% | 2.5% | -20.1% |
| 13 | BAKER BROS. ADVISORS LP | 2.4M | $88.0M | 0.4% | 2.2% | 0.0% |
| 14 | Polar Capital Holdings PlcNEW | 2.3M | $85.1M | 0.2% | 2.2% | new |
| 15 | Pictet Asset Management Holding SA | 2.1M | $77.6M | 0.1% | 2% | +10.1% |
| 16 | T. Rowe Price Investment Management, Inc. | 2.0M | $75.2M | 0.0% | 1.9% | +3.6% |
| 17 | GW&K Investment Management, LLC | 1.7M | $64.8M | 0.5% | 1.6% | +6.9% |
| 18 | BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 1.7M | $62.8M | 0.1% | 1.6% | -2.2% |
| 19 | Siren, L.L.C. | 1.4M | $53.2M | 1.1% | 1.3% | -25.4% |
| 20 | JPMORGAN CHASE & CO | 1.4M | $50.6M | 0.0% | 1.3% | +3.0% |
| 21 | First Light Asset Management, LLC | 1.4M | $50.9M | 3.1% | 1.3% | +24.9% |
| 22 | MORGAN STANLEY | 1.3M | $50.1M | 0.0% | 1.3% | +45.5% |
| 23 | BANK OF AMERICA CORP /DE/ | 1.3M | $49.9M | 0.0% | 1.3% | +86.2% |
| 24 | NOVO HOLDINGS A/S | 1.3M | $49.4M | 2.9% | 1.3% | -14.8% |
| 25 | DIMENSIONAL FUND ADVISORS LP | 1.3M | $47.5M | 0.0% | 1.2% | +49.1% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.